Latest Commercialisation News

Paradigm Biopharmaceuticals has reached key milestones in its global Phase 3 trial for knee osteoarthritis, activating its first Australian clinical site and enrolling the first patient. With multiple sites in Australia and the US preparing for recruitment, the trial is advancing steadily toward critical data readouts.

EMVision Medical Devices has activated two additional key sites in its pivotal trial for the emu™ bedside brain scanner, advancing its path toward FDA clearance. These new sites join a growing network of leading stroke centres across the US and Australia.

Volt Resources has reshaped its executive team to sharpen focus on downstream graphite refining and advanced materials, appointing Trevor Matthews to its board while repositioning CEO Prashant Chintawar.

ReNerve Limited has entered a strategic partnership with Berkeley Biologics to develop and commercialise two new tissue-based product ranges, aiming to expand its footprint in the US surgical market by the end of 2025.

Neurotech International has reported positive human pharmacokinetic results for NTI164, a cannabinoid formulation designed for paediatric neurological disorders, confirming rapid absorption and a non-intoxicating profile.

Green Critical Minerals has raised A$7 million through an institutional placement to accelerate the commercial rollout of its Very High Density graphite technology, aiming for first revenue in early 2026.

Iondrive Limited is expanding its proprietary Deep Eutectic Solvent technology into the burgeoning e-waste urban mining sector, backed by a South Australian government grant. The company aims to recover valuable metals from printed circuit boards, tapping into a global market worth billions yet largely unrecycled.

TruScreen Group Limited has successfully raised NZ$2.35 million through a share placement, attracting new institutional investors from Asia, while launching a discounted share purchase plan for existing shareholders.

Delta Lithium Limited has announced a proposed demerger involving an in-specie distribution of over 63 million Ballard Mining shares to eligible shareholders, pending approval at a June 30 meeting. This move will reduce Delta's stake in Ballard and set the stage for Ballard's eventual ASX listing.

Papyrus Australia has secured a pivotal contract with UniSA to establish a Rapid Prototyping and R&D facility, advancing its sustainable packaging technology and commercial production plans.

Sparc Technologies has entered a strategic collaboration with Detmold Packaging to develop graphene-enhanced paper packaging products that promise improved durability and sustainability.

Nanollose Limited has appointed Andrew Moullin as its new CEO and Managing Director, aiming to leverage his extensive commercial expertise to fast-track the company’s microbial cellulose technology towards market readiness.